Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1/2 1

Status

Completed 4Recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 8OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Dermatologic 1

Conditions

Urinary Bladder Neoplasms 3Recurrence 1Keratosis, Actinic 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × 5-aminolevulinic acid hexyl ester × Clear all
NCT03058705 2019-08-19

Near Infrared Fluorescence Imaging for Bladder Cancer Detection

University of Rochester

Phase NA Completed
10 enrolled 5 charts
Genitourinary

Urinary Bladder Neoplasms

NCT02660190 2019-08-14

DaBlaCa-11

Aarhus University Hospital

Phase 3 Completed
696 enrolled
Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT01750970 2016-09-21

Endoscopic Resection of Bladder Tumors

Hopital Foch

Phase NA Completed
68 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02149342 2016-07-11

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Completed
14 enrolled 8 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡